| Literature DB >> 19342624 |
Xikui Liu1, Maria Alexiou, Natalia Martin-Orozco, Yeonseok Chung, Roza I Nurieva, Li Ma, Qiang Tian, George Kollias, Sijie Lu, Daniel Graf, Chen Dong.
Abstract
T cell activation and tolerance are delicately regulated by costimulatory molecules. Although B and T lymphocyte attenuator (BTLA) has been shown as a negative regulator for T cell activation, its role in peripheral T cell tolerance induction in vivo has not been addressed. In this study, we generated a novel strain of BTLA-deficient mice and used three different models to characterize the function of BTLA in controlling T cell tolerance. In an oral tolerance model, BTLA-deficient mice were found resistant to the induction of T cell tolerance to an oral Ag. Moreover, compared with wild-type OT-II cells, BTLA(-/-) OT-II cells were less susceptible to tolerance induction by a high-dose OVA peptide administered i.v. Finally, BTLA(-/-) OT-I cells caused autoimmune diabetes in RIP-mOVA recipient mice. Our results thus demonstrate an important role for BTLA in the induction of peripheral tolerance of both CD4(+) and CD8(+) T cells in vivo.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19342624 PMCID: PMC2767106 DOI: 10.4049/jimmunol.0803161
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422